Eisai, INC.

human health care company

Based in DC

🤖

AI Overview

With $1.4M in lobbying spend across 32 quarterly filings, Eisai, INC is a significant lobbying presence. They deploy 11 individual lobbyists Their lobbying covers 5 issue areas. Active from 2018 to 2025.

$1.4M
Total Spend
8
Years Active
1
Firms Hired
11
Lobbyists Deployed
5
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2018$160K
2019$160K
2020$160K
2021$160K
2022$160K
2023$190K
2024$200K
2025$200K

Issues Lobbied

Lobbying Firms

Lobbyists

Government Agencies Targeted

These are the government entities that Eisai, INC. disclosed contacting in their lobbying filings.

Centers For Medicare and Medicaid Services (CMS)HOUSE OF REPRESENTATIVESOffice of Management & Budget (OMB)SENATEExecutive Office of the President (EOP)U.S. Trade Representative (USTR)
View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Taxation, Health Issues, Medicare/Medicaid, Trade, Budget/Appropriations

Implementation of H.R.1, Tax Cuts and Jobs Act (P.L.115-97).

S.870, Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017, Senate Chronic Disease Initiative; S.204/H.R.878, Trickett Wendler Right to Try Act of 2017;

H.R.1953/S.830, Treat and Reduce Obesity Act of 2017; issues related to Part D coverage for obesity medications.

Part D Medicare Program (including Coverage Gap and other offsets in H.R.1892/P.L.115-1

Regulatory and legislative health care issues, including the 340B program;

Implementation of the Chronic Care Act of 2017;

H.R.878, Trickett Wendler Right to Try Act of 2017/S.204, Trickett Wendler, F

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.